Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - TOTAL RECEIVABLES
Total Receivables AKBA - Akebia Therapeutics, Inc.
39.3 M
LAST VALUE
-12.72%
2 YEAR CAGR
18.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR